After a turbulent six weeks, healthcare investors and dealmakers are operating in a markedly more unpredictable macro-economic environment. Next week, LaingBuisson's annual Investing in Healthcare conference offers a timely forum to take stock of where the healthcare market stands, how investment in the market has changed in the last few years and the opportunities the wider sector offers.
Date:
|
Venue:
|
Host:
|
Ashfords is once again supporting the annual LaingBuisson conference, which provides expert analysis and forecasts for the sector, and explores the changing landscape of private healthcare (including health real estate) investment. LaingBuisson is a leading provider of health and social care market intelligence and the official supplier of independent sector healthcare market data to the UK government's Office for National Statistics. This year's conference chair is Martin Chamberlin, Managing Director and Head of European Healthcare at Oppenheimer Europe.
Ongoing volatility is reshaping the conditions in which transactions are conceived, structured, negotiated, and completed. Investor sentiment is being tested, valuations are under pressure, and regulatory complexity has deepened. Against this backdrop, the conference offers healthcare leaders, investors, and advisers a chance to examine the challenges shaping the sector head-on.
Jocelyn Ormond, Ashfords’ healthcare and life sciences sector lead and a corporate partner, will chair a panel discussion with investors Christian Gylling Co-founder of Evolen Capital Partners, Ben Long Managing Partner of Atlas Health and Liam Goddard Co-founder of 22TwentyTwo. The session will focus on on investor sentiment and the challenges currently shaping healthcare M&A. The panel will examine the practical realities of getting deals approved and across the line in the current environment.
Commenting ahead of the event, Jocelyn Ormond said:
"While the appetite for investment in healthcare remains resilient, the need for a clear understanding of operating and regulatory risks has never been greater, the headwinds against which deals are completed have become more challenging and the execution of these deals has become harder to manage successfully. This conference could not be more timely in enabling all participants to share their insights into the ingredients for a successful investment."
Ashfords' healthcare and life sciences team has a strong track record supporting institutional investors, healthcare providers, and growth businesses across the full lifecycle of development, operation and investment. The firm provides support on key legal matters from executing mergers and acquisitions and assisting with the raising of growth capital to advising on healthcare regulation, data protection, debt finance, employment/immigration, and real estate.
